Drug safety reform at the FDA--pendulum swing or systematic improvement?
Publication
, Journal Article
McClellan, M
Published in: The New England journal of medicine
April 2007
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
The New England journal of medicine
DOI
EISSN
1533-4406
ISSN
0028-4793
Publication Date
April 2007
Volume
356
Issue
17
Start / End Page
1700 / 1702
Related Subject Headings
- United States Food and Drug Administration
- United States
- Product Surveillance, Postmarketing
- Humans
- Health Care Reform
- Government Regulation
- General & Internal Medicine
- Fees and Charges
- Drug Prescriptions
- Drug Industry
Citation
APA
Chicago
ICMJE
MLA
NLM
McClellan, M. (2007). Drug safety reform at the FDA--pendulum swing or systematic improvement? The New England Journal of Medicine, 356(17), 1700–1702. https://doi.org/10.1056/nejmp078057
McClellan, Mark. “Drug safety reform at the FDA--pendulum swing or systematic improvement?” The New England Journal of Medicine 356, no. 17 (April 2007): 1700–1702. https://doi.org/10.1056/nejmp078057.
McClellan M. Drug safety reform at the FDA--pendulum swing or systematic improvement? The New England journal of medicine. 2007 Apr;356(17):1700–2.
McClellan, Mark. “Drug safety reform at the FDA--pendulum swing or systematic improvement?” The New England Journal of Medicine, vol. 356, no. 17, Apr. 2007, pp. 1700–02. Epmc, doi:10.1056/nejmp078057.
McClellan M. Drug safety reform at the FDA--pendulum swing or systematic improvement? The New England journal of medicine. 2007 Apr;356(17):1700–1702.
Published In
The New England journal of medicine
DOI
EISSN
1533-4406
ISSN
0028-4793
Publication Date
April 2007
Volume
356
Issue
17
Start / End Page
1700 / 1702
Related Subject Headings
- United States Food and Drug Administration
- United States
- Product Surveillance, Postmarketing
- Humans
- Health Care Reform
- Government Regulation
- General & Internal Medicine
- Fees and Charges
- Drug Prescriptions
- Drug Industry